HOME Top Market Reports Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market by Product/Brand (GEM 4000, GEM 3000, i-STAT, ABL900, ABL90, cobas b 221, RAPIDLab), Player/Company (Radiometer, Instrumentation Laboratory, Siemens, Abbott, Alere) - Global Forecasts to 2021

Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market by Product/Brand (GEM 4000, GEM 3000, i-STAT, ABL900, ABL90, cobas b 221, RAPIDLab), Player/Company (Radiometer, Instrumentation Laboratory, Siemens, Abbott, Alere) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: July 2016
Report Code: MD 4435

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global blood gas analyzer market is expected to reach USD 636.0 Million by 2021 from USD 506.9 Million in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The growing number of patients being treated in ICUs, NICUs, and emergency departments is one of the major factors driving market growth. Growth in this market will also be driven by the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation Electrolyte Analyzer. Also, the growing demand for technology-integrated combined systems and miniaturization of POC blood gas analyzer are expected to provide growth opportunities in the coming years. However, the major challenges for the growth of this market include the presence of an unfavorable reimbursement scenario across the globe and the complexities involved in interpretation of data.

The blood gas analyzer market is segmented on the basis of major product brands (i-STAT, ePOC, GEM 3000, GEM 3500, GEM 4000, ABL800, ABL80, ABL90, cobas b 221, cobas b 121, cobas b 123, and RAPID Series). The report also provides market analysis from both value and volume perspectives.  GEM 3000 from Instrumentation Laboratory is estimated to account for the largest share of the global market in 2016. On the other hand, epoc from Alere is estimated to grow at the highest CAGR by 2021, owing to its portability and point-of-care characteristics.

Based on region, the global blood gas analyzer market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to command the major market share in 2016; the large share of this regional segment can be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in the region. Europe is expected to account for the second-largest share of the global market. Factors such as increasing number of POC testing-related conferences, new product launches, and rising demand for patient bedside testing in this region will drive the growth of this market. The Asia-Pacific region, however, is estimated to grow at the highest CAGR during the forecast period. Factors such as growing initiatives by market players and increasing patient population base will drive the growth of the market in this region.

The major players in the global blood gas analyzer market are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany). The top 3 companies together account for a share of more than 70% of the global market.

Target audience for the report:

  • Medical Device Companies
  • Vendors/Service Providers
  • Healthcare Service Providers
  • Business Research and Consulting Firms
  • Health Insurance Players
  • Diagnostic Centers
  • Research Institutions
  • Venture Capitalists
  • Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

Blood Gas Analyzer Market, by Product/Brand

  • I-STAT
  • cobas b221
  • cobas b123
  • cobas b121
  • epoc
  • ABL80
  • ABL90
  • ABL800
  • GEM 3000
  • GEM 3500
  • GEM 4000
  • RAPID Series
  • Others

Blood Gas Analyzer Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Customization Options:

  • No. of units sold for major brands in each geography
  • No. of units sold for major brands at country level
  • Further breakdown of RoW into regions or countries

Table of Contents

1. Introduction
    1.1 Objectives of the Study
    1.2 Blood Gas Analyzer Market Definition
    1.3 Blood Gas Analyzer Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders
    1.6 Assumptions & Limitations

2. Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
           2.1.3 Assumptions
    2.2 Blood Gas Analyzer Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Data Triangulation

3. Executive Summary
    3.1 Introduction

4. Market Overview
    4.1 Introduction
    4.2 Blood Gas Analyzer Market Segmentation
    4.3 Blood Gas Analyzer Market Dynamics
           4.3.1 Drivers
                    4.3.1.1 Rise in Aging Population and Subsequent Increase in Chronic Disease Prevalence
                    4.3.1.2 Reduction in Critical Care Costs
                    4.3.1.3 Inadequacy of Alternative Techniques
                    4.3.1.4 Growing Demand for PoC Analyzers
           4.3.2 Restraints
                    4.3.2.1 Unfavorable Reimbursement Scenario
                    4.3.2.2 Complex Operations & Interpretation of Data
           4.3.3 Opportunities
                    4.3.3.1 Rising Demand for Technology-Integrated Combined Systems
                    4.3.3.2 Miniaturization of PoC Blood Gas Analyzer
           4.3.4 Threats/Challenges
                    4.3.4.1 Non-Fda-Approved Blood Gas Analyzer and Refurbished Devices
                    4.3.4.2 Lack of Data Analysis Software
    4.4 Trends
           4.4.1 Technological Advancements in Blood Gas Analyzer
           4.4.2 Demand for PoC and Automated Devices Expected to Increase
           4.4.3 Price of Analyzers Will Increase Slightly in the Near Future

5. Global Blood Gas Analyzer Market Revenue, By Company

6. Global Blood Gas Analyzer Market Revenue, By Product
    6.1 Introduction
    6.2 i-Stat (Abbott Laboratories) Blood Gas Analyzer
    6.3 ePOC (Alere, Inc.) Blood Gas Analyzer
    6.4 GEM Premier (Instrumentation Laboratory) Blood Gas Analyzer
    6.5 ABL Flex (Radiometer) Blood Gas Analyzer
    6.6 Cobas (Roche Diagnostics) Blood Gas Analyzer
    6.7 RAPID Series (Siemens Healthineers) Blood Gas Analyzer
    6.8 Other* Blood Gas Analyzer

7. Blood Gas Analyzer Market, By Region
    7.1 Introduction
    7.2 North America
    7.3 Europe
    7.4 Asia-Pacific
    7.5 Rest-Of-The-World (RoW)

8. Competitive Landscape
    8.1 Introduction
    8.2 Market Share Analysis, By Key Player, 2015
    8.3 Competitive Scenario
    8.4 Recent Developments
           8.4.1 New Product Launches
           8.4.2 Acquisitions
           8.4.3 Collaborations
           8.4.4 Agreements
           8.4.5 Product Enhancement
           8.4.6 Product Approval
           8.4.7 Investment
           8.4.8 Other Developments

9. Company Profiles
    9.1 Radiometer Medical Aps (A Subsidiary of Danaher Corporation)
    9.2 Instrumentation Laboratory (A Werfen Company)
    9.3 Siemens AG
    9.4 Abbott Laboratories, Inc.
    9.5 Roche Diagnostics Limited
    9.6 Nova Biomedical
    9.7 OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.)
    9.8 ERBA Diagnostics Mannheim GmbH
    9.9 Medica Corporation


List of Tables (38 Tables)

Table 1 Blood Gas Analyzer Market, By Geography, 2014-2021 (USD Million)
Table 2 Global Market Size, By Player, 2014–2021 (USD Million)
Table 3 Global Market Size, By Player, 2014–2021 (No. of Units)
Table 4 Global Market Size, By Product, 2014–2021 (USD Million)
Table 5 Global Market Size, By Product, 2014–2021 (No. of Units)
Table 6 Global i-Stat (Abbott Laboratories) Market Size, By Product, 2014–2021 (USD Million)
Table 7 Global i-Stat (Abbott Laboratories) Market Size, By Product, 2014–2021 (No. of Units)
Table 8 Global i-Stat (Abbott Laboratories) Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global ePOC (Alere, Inc.) Market Size, By Product, 2014–2021 (USD Million)
Table 10 Global ePOC (Alere, Inc.) Market Size, By Product, 2014–2021 (No. of Units)
Table 11 Global ePOC (Alere, Inc.) Market Size, By Region, 2014–2021 (USD Million)
Table 12 Global GEM Premier (Instrumentation Laboratory) Market Size, By Brand, 2014–2021 (USD Million)
Table 13 Global GEM Premier (Instrumentation Laboratory) Market Size, By Brand, 2014–2021 (No. of Units)
Table 14 Global GEM Premier (Instrumentation Laboratory) Blood Gas Analyzer Market Size, By Region, 2014–2021 (USD Million)
Table 15 Global ABL Flex (Radiometer) Electrolyte Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 16 Global ABL Flex (Radiometer) Electrolyte Analyzer Market Size, By Product, 2014–2021 (No. of Units)
Table 17 Global ABL Flex (Radiometer) Electrolyte Analyzer Market Size, By Region, 2014–2021 (USD Million)
Table 18 Global Cobas (Roche Diagnostics) Electrolyte Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 19 Global Cobas (Roche Diagnostics) Electrolyte Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 20 Global Cobas (Roche Diagnostics) Electrolyte Analyzer Market Size, By Region, 2014–2021 (USD Million)
Table 21 Global RAPID Series (Siemens Healthineers) Electrolyte Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 22 Global RAPID Series (Siemens Healthineers) Electrolyte Analyzer Market Size, By Product, 2014–2021 (No. of Units)
Table 23 Global RAPID Series (Siemens Healthineers) Electrolyte Analyzer Market Size, By Region, 2014–2021 (USD Million)
Table 24 Global Other* Electrolyte Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 25 Global Other* Electrolyte Analyzer Market Size, By Region, 2014–2021 (USD Million)
Table 26 Electrolyte Analyzer Market, By Geography, 2014-2021 (USD Million)
Table 27 North American Market, By Player, 2014-2021 (USD Million)
Table 28 European Market, By Player, 2014-2021 (USD Million)
Table 29 Asia-Pacific Market, By Player, 2014-2021 (USD Million)
Table 30 RoW Market, By Player, 2014-2021 (USD Million)
Table 31 New Product Launches (2013–2016) (Till June) (Cntd…)
Table 32 Acquisitions (2013-2016) (Till June)
Table 33 Collaboration (2013-2016) (Till June)
Table 34 Agreements (2013-2016) (Till June)
Table 35 Product Enhancement (2013-2016) (Till June)
Table 36 Product Approval (2013-2016) (Till June)
Table 37 Investment (2013-2016) (Till June)
Table 38 Other Developments (2013-2016) (Till June)


List of Figures (14 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Diagram
Figure 4 Market Size Estimation Steps
Figure 5 Market Data Triangulation Methodology
Figure 6 Market Size, 2016 vs. 2021 (USD Million)
Figure 7 Electrolyte Analyzer Market Dynamics
Figure 8 Global Electrolyte Analyzer Market Size, By Player, 2016 vs. 2021 (USD Million)
Figure 9 Global Electrolyte Analyzer Market Size, By Player, 2016 vs. 2021 (No. of Units)
Figure 10 Global Electrolyte Analyzer Market Size, By Brand, 2016 vs. 2021 (USD Million)
Figure 11 Global Electrolyte Analyzer Market, By Brand, 2016 vs. 2021 (No. of Units)
Figure 12 Leading Market Players Adopted New Product Launches as Key Growth Strategies During 2013-2016 (Till June)
Figure 13 Global Electrolyte Analyzer Market Share, By Key Player (2015)
Figure 14 New Product Launches—Most-Widely Adopted Growth Strategy By Market Players From 2013 to 2016 (Till June)

The global blood gas analyzer market is expected to reach USD 636.0 Million by 2021 from USD 506.9 Million in 2016, at a CAGR of 4.6%. Growth in this market can majorly be attributed to the rising demand for automated and point-of-care Electrolyte Analyzer devices. Also, the market will be further driven by the growing number of patients being treated in ICUs, NICUs, and emergency departments; the increasing adoption of technologically advanced biosensors and data analysis software is expected to supported market growth in the coming years. The commercialization of innovative POC blood gas analyzer based on miniaturized sensors is expected to offer potential growth opportunities to players operating in this market.

In this report, the blood gas analyzer market is segmented on the basis of key players, major product brands (i-STAT, ePOC, GEM 3000, GEM 3500, GEM 4000, ABL800, ABL80, ABL90, cobas b 221, cobas b 121, cobas b 123, and RAPID Series) in major regions—North America, Europe, APAC and Rest of the World. This report analyzes the market from both value and volume perspectives.

In 2016, GEM 3000 is expected to account for the largest share of the global blood gas analyzer market. This is mainly because GEM 3000 delivers real-time system diagnostics, requires low labor-intensive system calibration, and eliminates lengthy equipment training and possible human errors. On the other hand, ePOC from Alere is expected to be the fastest-growing product brand in the coming years, primarily due to its point-of-care offerings.

North America is estimated to dominate the global blood gas analyzer market in 2016. The large share of this regional segment can primarily be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives. On the other hand, the Asia-Pacific market is expected to witness the highest growth during the forecast period, owing to factors such as growing initiatives by market players and increasing patient population base in this region.

Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market

Reimbursement issues may restrain the growth of the blood gas analyzer market in many countries as healthcare providers face many challenges in POCT billing. Also, complex operations and interpretation of data for these analyzers will hinder their adoption, especially in home care settings.

The key players in the global blood gas analyzer market are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany), with Radiometer leading the market. Players in this market adopted organic (new product launch) as well as inorganic growth strategies (acquisitions and agreements) to enhance their market shares and positions. New product launch was the most dominant strategy adopted by market players between 2013 and 2016.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo